MRNA Synthesis and Manufacturing Market - Global Forecast To 2029
商品番号 : SMB-67673
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年10月 |
| ページ数 | 344 |
| 図表数 | 535 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The mRNA synthesis and manufacturing market is expected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024, at a CAGR of 3.4% during the forecast period.
mRNA合成・製造市場は、予測期間中に3.4%のCAGRで、2024年の6億2,440万米ドルから2029年には7億3,830万米ドルに達すると予想されます。
mRNA therapeutics hold promise as the next generation of drugs for tissue restoration in regenerative medicine. The development of non-immunogenic mRNA can be achieved through the use of modified nucleosides, which enhances safety and efficacy. By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription. Furthermore, effective delivery strategies tailored specifically for mRNA are crucial for the advancement of these therapies. The processes involved in loading and releasing mRNA from biomaterials are essential for their application in tissue restoration and require further refinement to maximize their potential.
“The transcription consumables segment accounted for the largest share by product segment in the mRNA synthesis and manufacturing market in 2023.”
Based on product, the mRNA synthesis and manufacturing market is segmented into consumables, and instrument. In 2023, the consumables segment accounted for the largest share of mRNA synthesis and manufacturing market; this segment is further segmented into transcription consumables, purification consumables, and analysis & characterization consumables. Dominance of the consumables segment throughout the forecast period is attributed to the fact that they are essential for mRNA synthesis and manufacturing. Unlike instruments, which are a one-time investment, consumables must be replenished regularly, leading to continuous demand. Also, the entire market operates majorly on instruments offered by Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), whereas more companies operate in the consumables space for mRNA synthesis and manufacturing.
“The mRNA synthesis & modification service segment is expected to grow at the highest growth rate in the mRNA synthesis and manufacturing market throughout the forecast period.”
Based on service, the mRNA synthesis and manufacturing market is segmented into mRNA synthesis & modification, mRNA purification, mRNA analysis & characterization, and manufacturing & scale-up. In 2023, the mRNA synthesis & modification segment accounted for the largest share of the mRNA synthesis and manufacturing market. A significant driver for the mRNA synthesis and modification services within the mRNA synthesis and manufacturing market is the growing need for customized mRNA sequences and modifications to enhance the efficacy and stability of therapeutic and vaccine candidates, which requires specialized synthesis and modification services. As the application of mRNA technology expands, researchers and developers increasingly seek tailored mRNA sequences that can be optimized for specific therapeutic outcomes, such as improved protein expression or enhanced immune response.
“The Asia Pacific region is growing at the highest CAGR in the mRNA synthesis and manufacturing market from 2024 to 2029.”
The mRNA synthesis and manufacturing market is segmented into six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the fastest-growing regional segment in the global mRNA synthesis and manufacturing market, Factors such as rising healthcare expenditure; growing R&D expansion in key markets such as India, China, and Japan; low labor costs; and the favorable regulatory environment in the region are expected to contribute to market growth. China’s mRNA synthesis and manufacturing market is driven by the country’s substantial government investments in biotech innovation, rapid expansion of domestic biotech infrastructure, and increasing international collaborations. In recent developments, China has demonstrated a strong commitment to advancing mRNA technology.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 55%, Tier 2 – 25%, and Tier 3 – 20%
- By Designation: Directors – 50%, Managers – 30%, and Others – 20%
- By Region: North America -40%, Europe -35%, Asia-Pacific -20%, ROW -5%
List of Companies Profiled in the Report:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (US)
- GenScript (US)
- New England Biolabs (US)
- AldevronLLC. (Danaher Corporation) (US)
- Promega Corporation (US)
- Sartorius AG (Germany)
- WuXi Biologics (China)
- Takara Bio Inc. (Japan)
- GENEWIZ (Azenta USInc.) (US)
- TriLink BioTechnologies (US)
- Lonza (Switzerland)
- Telesis Bio Inc. (US)
- Aurigene Pharmaceutical Services Ltd. (Dr. Reddy’s Laboratories Ltd.) (India)
- ST Pharm (South Korea)AGC Biologics (US)
Research Coverage:
This research report categorizes the mRNA synthesis and manufacturing market by Product (transcription consumables, purification consumables, analysis & characterization consumables, and instrument), Application (cell and gene therapy, vaccine, and other applications), End User (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the mRNA synthesis and manufacturing market. Competitive analysis of top players and upcoming startups in the mRNA synthesis and manufacturing market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mRNA synthesis and manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mrna technology, advancements in mrna synthesis technology, increased outsourcing for mrna synthesis and modification, and collaborations among industry players), restraints (High production cost, stringent regulations), opportunities (Advancements in drug delivery technologies, increased government funding and private investment, applications in regenerative medicines), and challenges (Stability, storage, and manufacturing scalability) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the mRNA synthesis and manufacturing market
- Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the mRNA synthesis and manufacturing market
Competitive Assessment: Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), GenScript (US), New England Biolabs (US), Aldevron, LLC. (Danaher Corporation) (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (Azenta US, Inc.) (US), TriLink BioTechnologies (US), Lonza (Switzerland), Telesis Bio Inc. (US), Aurigene Pharmaceutical Services Ltd. (Dr. Reddy’s Laboratories Ltd.) (India), ST Pharm (South Korea), AGC Biologics (US), among others in the market.
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 34
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 35
1.3.2 INCLUSIONS AND EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 36
1.4 CURRENCY CONSIDERED 36
1.5 STAKEHOLDERS 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY DATA 39
2.2 MARKET SIZE ESTIMATION 41
2.2.1 GLOBAL MARKET SIZE ESTIMATION 42
2.2.2 INSIGHTS FROM PRIMARY SOURCES 45
2.2.3 TOP-DOWN APPROACH 45
2.3 GROWTH RATE PROJECTIONS 46
2.4 DATA TRIANGULATION 48
2.5 RESEARCH ASSUMPTIONS 49
2.6 RESEARCH LIMITATIONS 50
2.7 RISK ANALYSIS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 56
4.1 MRNA SYNTHESIS & MANUFACTURING MARKET OVERVIEW 56
4.2 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT AND COUNTRY, 2023 57
4.3 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: GLOBAL GROWTH OPPORTUNITIES 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
5.2.1 DRIVERS 59
5.2.1.1 Rise in clinical trials for mRNA vaccines 59
5.2.1.2 Continuous improvements in design, delivery systems, and manufacturing processes 60
5.2.1.3 Increased outsourcing of mRNA synthesis and production 61
5.2.1.4 Advantages of mRNA-based technology over recombinant expression 61
5.2.2 RESTRAINTS 62
5.2.2.1 High production cost 62
5.2.2.2 Stringent regulations 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Ongoing innovations in nanoparticles and cell-specific delivery technologies 63
5.2.3.2 Expanding applications of mRNA technology 63
5.2.3.3 Increased government funding and private investments 65
5.2.4 CHALLENGES 66
5.2.4.1 Stability, storage, and manufacturing scalability issues 66
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66
5.4 REGULATORY LANDSCAPE 67
5.4.1 REGULATORY SCENARIO 67
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.5 VALUE CHAIN ANALYSIS 71
5.6 TECHNOLOGY ANALYSIS 72
5.6.1 KEY TECHNOLOGIES 72
5.6.1.1 In vitro transcription 72
5.6.1.2 Poly(A) tail synthesis 73
5.6.1.3 RNA stabilization technologies 73
5.6.2 COMPLEMENTARY TECHNOLOGIES 73
5.6.2.1 Next-generation sequencing 73
5.6.2.2 Gene cloning and vector construction 74
5.6.2.3 DNA amplification 74
5.6.3 ADJACENT TECHNOLOGIES 74
5.6.3.1 Spectrophotometry 74
5.6.3.2 Electrophoresis 75
5.6.3.3 High-performance liquid chromatography 75
5.7 PRICING ANALYSIS 75
5.7.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT 76
5.7.2 AVERAGE SELLING PRICE TREND FOR CONSUMABLES 76
5.7.3 AVERAGE SELLING PRICE, BY REGION 77
5.8 PATENT ANALYSIS 78
5.9 SUPPLY CHAIN ANALYSIS 79
5.10 ECOSYSTEM ANALYSIS 81
5.11 KEY CONFERENCES AND EVENTS, 2024–2025 83
5.12 PORTER’S FIVE FORCES ANALYSIS 84
5.12.1 INTENSITY OF COMPETITIVE RIVALRY 85
5.12.2 BARGAINING POWER OF SUPPLIERS 85
5.12.3 BARGAINING POWER OF BUYERS 85
5.12.4 THREAT OF SUBSTITUTES 85
5.12.5 THREAT OF NEW ENTRANTS 86
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 86
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 86
5.13.2 KEY BUYING CRITERIA, BY END USER (PRODUCT) 87
5.14 INVESTMENT AND FUNDING SCENARIO 88
5.15 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET 88
6 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT 90
6.1 INTRODUCTION 91
6.2 CONSUMABLES 92
6.2.1 TRANSCRIPTION CONSUMABLES 94
6.2.1.1 mRNA synthesis kits 97
6.2.1.1.1 Increasing demand for rapid and efficient mRNA vaccine development to augment growth 97
6.2.1.2 mRNA profiling kits 99
6.2.1.2.1 Growing need for precision medicine and personalized therapies to propel market 99
6.2.1.3 RNA polymerases 101
6.2.1.3.1 Growing demand for high-quality and scalable mRNA production to boost market 101
6.2.1.4 Plasmid DNA/DNA templates 103
6.2.1.4.1 Rapid growth of mRNA-based therapeutics and vaccines to expedite growth 103
6.2.1.5 Nucleotides 105
6.2.1.5.1 Need to support diverse research & development initiatives to promote growth 105
6.2.1.6 Vectors 107
6.2.1.6.1 Need for reliable and high-capacity vectors to propel market 107
6.2.1.7 Other transcription consumables 109
6.2.2 PURIFICATION CONSUMABLES 111
6.2.2.1 Purification kits & reagents 114
6.2.2.1.1 Rising focus on quality assurance to encourage growth 114
6.2.2.2 Chromatography filters & membranes 116
6.2.2.2.1 Growing emphasis on process optimization and cost-efficiency in large-scale production to drive market 116
6.2.2.3 Other purification consumables 118
6.2.3 ANALYSIS & CHARACTERIZATION CONSUMABLES 120
6.2.3.1 Analysis kits & reagents 122
6.2.3.1.1 Emerging applications of mRNA beyond vaccines to support growth 122
6.2.3.2 Other analysis & characterization consumables 124
6.3 INSTRUMENTS 126
6.3.1 NEED TO REDUCE PRODUCTION COST AND HIGHER SCALABILITY TO PROMOTE GROWTH 126
7 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION 129
7.1 INTRODUCTION 130
7.2 CELL & GENE THERAPIES 130
7.2.1 RISING ADOPTION OF MRNA TECHNOLOGY TO TREAT GENETIC DISORDERS AND CANCER TO FUEL MARKET 130
7.3 VACCINES 132
7.3.1 INCREASING DEVELOPMENT AND DEPLOYMENT OF MRNA VACCINES TO ACCELERATE GROWTH 132
7.4 OTHER APPLICATIONS 134
8 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER 137
8.1 INTRODUCTION 138
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 138
8.2.1 NEED TO RESPOND TO EMERGING INFECTIOUS DISEASES TO DRIVE MARKET 138
8.3 ACADEMIC & RESEARCH INSTITUTIONS 141
8.3.1 INCREASING INVESTMENTS IN RESEARCH TO EXPEDITE GROWTH 141
8.4 CROS & CDMOS 143
8.4.1 RISING DEMAND FOR OUTSOURCED SERVICES TO AID GROWTH 143
9 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE 146
9.1 INTRODUCTION 147
9.2 MRNA SYNTHESIS & MODIFICATION SERVICES 147
9.2.1 GROWING NEED FOR CUSTOMIZED MRNA SEQUENCES AND MODIFICATIONS TO FUEL MARKET 147
9.3 MRNA PURIFICATION SERVICES 149
9.3.1 NEED FOR PERSONALIZED MRNA VACCINES TO BOOST MARKET 149
9.4 MRNA ANALYSIS & CHARACTERIZATION SERVICES 151
9.4.1 INCREASING REGULATORY SCRUTINY TO EXPEDITE GROWTH 151
9.5 MANUFACTURING & SCALE-UP SERVICES 153
9.5.1 GROWING TRANSITION FROM SMALL-SCALE RESEARCH & DEVELOPMENT TO LARGE-SCALE COMMERCIAL PRODUCTION TO DRIVE MARKET 153
10 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER 156
10.1 INTRODUCTION 157
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 157
10.2.1 RAPID DEVELOPMENT AND COMMERCIALIZATION OF MRNA-BASED PRODUCTS TO ENCOURAGE GROWTH 157
10.3 ACADEMIC & RESEARCH INSTITUTIONS 160
10.3.1 INCREASING EMPHASIS ON TRANSLATING MRNA-BASED DISCOVERIES INTO PRACTICAL APPLICATIONS TO AID GROWTH 160
10.4 SMALL-SCALE CROS & CDMOS 162
10.4.1 NEED FOR SPECIALIZED AND FLEXIBLE PRODUCTION IN BIOTECH COMPANIES AND EARLY-STAGE MRNA PROJECTS TO BOOST MARKET 162
11 MRNA SYNTHESIS & MANUFACTURING MARKET, BY REGION 165
11.1 INTRODUCTION 166
11.2 NORTH AMERICA 167
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 171
11.2.2 US 172
11.2.2.1 Increasing demand for mRNA-based vaccines and therapeutics to accelerate growth 172
11.2.3 CANADA 176
11.2.3.1 Increasing collaborations between academic institutions and market players to spur growth 176
11.3 EUROPE 179
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 183
11.3.2 GERMANY 184
11.3.2.1 Growing establishment of manufacturing sites to boost market 184
11.3.3 UK 188
11.3.3.1 Presence of state-of-the-art facilities to support growth 188
11.3.4 FRANCE 191
11.3.4.1 Favorable government support for biopharmaceutical production to drive market 191
11.3.5 SWITZERLAND 195
11.3.5.1 Robust biotech sector and production facilities to promote growth 195
11.3.6 ITALY 198
11.3.6.1 Increasing collaborations among biotech firms and manufacturing facilities to aid growth 198
11.3.7 SPAIN 202
11.3.7.1 Growing investments in biotechnology to fuel market 202
11.3.8 REST OF EUROPE 205
11.4 ASIA PACIFIC 209
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 214
11.4.2 CHINA 214
11.4.2.1 Rapid expansion of domestic biotech sector to contribute to growth 214
11.4.3 JAPAN 218
11.4.3.1 Growing strategic investments in biotechnology infrastructure to boost market 218
11.4.4 INDIA 221
11.4.4.1 Booming biotech sector and international collaborations to augment growth 221
11.4.5 SOUTH KOREA 225
11.4.5.1 Increased government funding in research and vaccine development to bolster growth 225
11.4.6 REST OF ASIA PACIFIC 228
11.5 LATIN AMERICA 232
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 236
11.5.2 BRAZIL 237
11.5.2.1 Increased funding for strengthening infrastructure to sustain growth 237
11.5.3 REST OF LATIN AMERICA 240
11.6 MIDDLE EAST 243
11.6.1 GROWING INVESTMENTS FROM PRIVATE SECTOR AND ACADEMIC RESEARCH INITIATIVES TO DRIVE MARKET 243
11.6.2 MACROECONOMIC OUTLOOK IN MIDDLE EAST 247
11.7 AFRICA 248
11.7.1 GROWING INITIATIVES TO ENHANCE LOCAL PRODUCTION CAPABILITIES TO PROPEL MARKET 248
11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 251
12 COMPETITIVE LANDSCAPE 252
12.1 INTRODUCTION 252
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021–AUGUST 2024 252
12.3 REVENUE ANALYSIS, 2019–2023 254
12.4 MARKET SHARE ANALYSIS, 2023 255
12.4.1 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET 255
12.4.2 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET 256
12.5 COMPANY VALUATION AND FINANCIAL METRICS 257
12.6 BRAND/SERVICE COMPARISON 259
12.6.1 ALDEVRON LLC (DANAHER CORPORATION) (US) 259
12.6.2 THERMO FISHER SCIENTIFIC INC. (US) 260
12.6.3 TRILINK BIOTECHNOLOGIES (US) 260
12.6.4 LONZA (SWITZERLAND) 260
12.6.5 MERCK KGAA (GERMANY) 260
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 260
12.7.1 STARS 261
12.7.2 EMERGING LEADERS 261
12.7.3 PERVASIVE PLAYERS 261
12.7.4 PARTICIPANTS 261
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 263
12.7.5.1 Company footprint 263
12.7.5.2 Region footprint 263
12.7.5.3 Product footprint 264
12.7.5.4 Service footprint 265
12.7.5.5 Application footprint 266
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 267
12.8.1 PROGRESSIVE COMPANIES 267
12.8.2 RESPONSIVE COMPANIES 267
12.8.3 DYNAMIC COMPANIES 267
12.8.4 STARTING BLOCKS 267
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 268
12.8.5.1 Detailed list of key startups/SMEs 268
12.8.5.2 Competitive benchmarking of key startups/SMES 269
12.9 COMPETITIVE SCENARIO 270
12.9.1 PRODUCT/SERVICE LAUNCHES 270
12.9.2 DEALS 271
12.9.3 EXPANSIONS 271
13 COMPANY PROFILES 273
13.1 KEY PLAYERS 273
13.1.1 THERMO FISHER SCIENTIFIC INC. 273
13.1.1.1 Business overview 273
13.1.1.2 Products/Services offered 274
13.1.1.3 Recent developments 276
13.1.1.3.1 Product/Service launches 276
13.1.1.3.2 Deals 276
13.1.1.3.3 Expansions 276
13.1.1.4 MnM view 277
13.1.1.4.1 Key strengths 277
13.1.1.4.2 Strategic choices 277
13.1.1.4.3 Weaknesses and competitive threats 277
13.1.2 DANAHER CORPORATION 278
13.1.2.1 Business overview 278
13.1.2.2 Products/Services offered 279
13.1.2.3 Recent developments 281
13.1.2.3.1 Product/Service launches 281
13.1.2.3.2 Deals 281
13.1.2.3.3 Expansions 281
13.1.2.4 MnM view 282
13.1.2.4.1 Key strengths 282
13.1.2.4.2 Strategic choices 282
13.1.2.4.3 Weaknesses and competitive threats 282
13.1.3 MERCK KGAA 283
13.1.3.1 Business overview 283
13.1.3.2 Products/Services offered 284
13.1.3.3 Recent developments 287
13.1.3.3.1 Deals 287
13.1.3.3.2 Expansions 287
13.1.3.4 MnM view 288
13.1.3.4.1 Key strengths 288
13.1.3.4.2 Strategic choices 288
13.1.3.4.3 Weaknesses and competitive threats 288
13.1.4 LONZA 289
13.1.4.1 Business overview 289
13.1.4.2 Products/Services offered 290
13.1.4.3 Recent developments 291
13.1.4.3.1 Deals 291
13.1.4.3.2 Expansions 291
13.1.4.4 MnM view 292
13.1.4.4.1 Key strengths 292
13.1.4.4.2 Strategic choices 292
13.1.4.4.3 Weaknesses and competitive threats 292
13.1.5 MARVAI LIFESCIENCES 293
13.1.5.1 Business overview 293
13.1.5.2 Products/Services offered 294
13.1.5.3 Recent developments 297
13.1.5.3.1 Product/Service launches 297
13.1.5.3.2 Deals 297
13.1.5.3.3 Expansions 298
13.1.5.4 MnM view 298
13.1.5.4.1 Key strengths 298
13.1.5.4.2 Strategic choices 298
13.1.5.4.3 Weaknesses and competitive threats 298
13.1.6 NEW ENGLAND BIOLABS 299
13.1.6.1 Business overview 299
13.1.6.2 Products/Services offered 299
13.1.6.3 Recent developments 300
13.1.6.3.1 Product/Service launches 300
13.1.7 PROMEGA CORPORATION 301
13.1.7.1 Business overview 301
13.1.7.2 Products/Services offered 301
13.1.7.3 Recent developments 302
13.1.7.3.1 Expansions 302
13.1.7.3.2 Other developments 302
13.1.8 GENSCRIPT 303
13.1.8.1 Business overview 303
13.1.8.2 Products/Services offered 304
13.1.8.3 Recent developments 305
13.1.8.3.1 Product/Service launches 305
13.1.8.3.2 Deals 306
13.1.8.3.3 Expansions 306
13.1.8.4 MnM view 307
13.1.8.4.1 Key strengths 307
13.1.8.4.2 Strategic choices 307
13.1.8.4.3 Weaknesses and competitive threats 307
13.1.9 WUXI BIOLOGICS 308
13.1.9.1 Business overview 308
13.1.9.2 Products/Services offered 309
13.1.9.3 Recent developments 310
13.1.9.3.1 Expansions 310
13.1.10 TAKARA BIO INC. 311
13.1.10.1 Business overview 311
13.1.10.2 Products/Services offered 312
13.1.10.3 Recent developments 313
13.1.10.3.1 Product/Service launches 313
13.1.10.3.2 Deals 313
13.1.11 SARTORIUS AG 314
13.1.11.1 Business overview 314
13.1.11.2 Products/Services offered 315
13.1.11.3 Recent developments 316
13.1.11.3.1 Deals 316
13.1.12 GENEWIZ 317
13.1.12.1 Business overview 317
13.1.12.2 Products/Services offered 318
13.1.13 TELESIS BIO INC. 319
13.1.13.1 Business overview 319
13.1.13.2 Products/Services offered 320
13.1.13.3 Recent developments 321
13.1.13.3.1 Product/Service launches 321
13.1.13.3.2 Deals 321
13.1.14 ST PHARM 322
13.1.14.1 Business overview 322
13.1.14.2 Products/Services offered 323
13.1.14.3 Recent developments 323
13.1.14.3.1 Deals 323
13.1.15 AGC BIOLOGICS 324
13.1.15.1 Business overview 324
13.1.15.2 Products/Services offered 324
13.1.15.3 Recent developments 325
13.1.15.3.1 Deals 325
13.1.15.3.2 Expansions 325
13.1.16 DR. REDDY’S LABORATORIES LTD. 326
13.1.16.1 Business overview 326
13.1.16.2 Products/Services offered 327
13.1.16.3 Recent developments 327
13.1.16.3.1 Expansions 327
13.2 OTHER PLAYERS 328
13.2.1 ETHERNA 328
13.2.2 BOC SCIENCES 329
13.2.3 BIOMAY AG 330
13.2.4 CURIA GLOBAL, INC. 331
13.2.5 JENA BIOSCIENCE GMBH 332
13.2.6 ENZYNOMICS CO., LTD. 333
13.2.7 KANEKA EUROGENTEC S.A. 334
13.2.8 VERNAL BIOSCIENCES 334
13.2.9 CELLSCRIPT 335
14 APPENDIX 336
14.1 DISCUSSION GUIDE 336
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 340
14.3 CUSTOMIZATION OPTIONS 342
14.4 RELATED REPORTS 342
14.5 AUTHOR DETAILS 343
LIST OF TABLES
TABLE 1 MRNA SYNTHESIS & MANUFACTURING MARKET: INCLUSIONS AND EXCLUSIONS 36
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 48
TABLE 3 MRNA SYNTHESIS & MANUFACTURING MARKET: RISK ANALYSIS 50
TABLE 4 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 59
TABLE 5 INDICATIVE LIST OF MRNA VACCINES IN CLINICAL TRIALS (AS OF JUNE 2023) 60
TABLE 6 INDICATIVE LIST OF MRNA-BASED DRUGS IN CLINICAL TRIALS (AS OF JUNE 2023) 64
TABLE 7 REGULATORY SCENARIO FOR MRNA SYNTHESIS & MANUFACTURING MARKET WORLDWIDE 67
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT,
2021–2023 (USD) 76
TABLE 13 AVERAGE SELLING PRICE TREND FOR CONSUMABLES, 2021–2023 (USD) 76
TABLE 14 AVERAGE SELLING PRICE, BY REGION, 2023 (USD) 77
TABLE 15 MRNA SYNTHESIS & MANUFACTURING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2024 78
TABLE 16 MRNA SYNTHESIS & MANUFACTURING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 82
TABLE 17 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY CONFERENCES AND EVENTS, 2024–2025 83
TABLE 18 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT OF PORTER’S FIVE FORCES 85
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 86
TABLE 20 KEY BUYING CRITERIA, BY PRODUCT END USER 87
TABLE 21 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 91
TABLE 22 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 92
TABLE 23 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 93
TABLE 24 EUROPE: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 93
TABLE 25 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 93
TABLE 26 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 94
TABLE 27 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 94
TABLE 28 TRANSCRIPTION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 95
TABLE 29 TRANSCRIPTION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 95
TABLE 30 NORTH AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 96
TABLE 31 EUROPE: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 96
TABLE 32 ASIA PACIFIC: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 96
TABLE 33 LATIN AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 97
TABLE 34 MRNA SYNTHESIS KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 98
TABLE 35 NORTH AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 98
TABLE 36 EUROPE: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 98
TABLE 37 ASIA PACIFIC: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 99
TABLE 38 LATIN AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 99
TABLE 39 MRNA PROFILING KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 100
TABLE 40 NORTH AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 100
TABLE 41 EUROPE: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 100
TABLE 42 ASIA PACIFIC: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 101
TABLE 43 LATIN AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 101
TABLE 44 RNA POLYMERASES MARKET, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 45 NORTH AMERICA: RNA POLYMERASES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 102
TABLE 46 EUROPE: RNA POLYMERASES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 102
TABLE 47 ASIA PACIFIC: RNA POLYMERASES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 103
TABLE 48 LATIN AMERICA: RNA POLYMERASES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 103
TABLE 49 PLASMID DNA/DNA TEMPLATES MARKET, BY REGION, 2022–2029 (USD MILLION) 104
TABLE 50 NORTH AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 104
TABLE 51 EUROPE: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 104
TABLE 52 ASIA PACIFIC: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 105
TABLE 53 LATIN AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 105
TABLE 54 NUCLEOTIDES MARKET, BY REGION, 2022–2029 (USD MILLION) 106
TABLE 55 NORTH AMERICA: NUCLEOTIDES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 106
TABLE 56 EUROPE: NUCLEOTIDES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 57 ASIA PACIFIC: NUCLEOTIDES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 58 LATIN AMERICA: NUCLEOTIDES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 107
TABLE 59 VECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 108
TABLE 60 NORTH AMERICA: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 61 EUROPE: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 62 ASIA PACIFIC: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 63 LATIN AMERICA: VECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 64 OTHER TRANSCRIPTION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 110
TABLE 65 NORTH AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 66 EUROPE: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 110
TABLE 67 ASIA PACIFIC: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 68 LATIN AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 69 PURIFICATION CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 112
TABLE 70 PURIFICATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 112
TABLE 71 NORTH AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 112
TABLE 72 EUROPE: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 113
TABLE 73 ASIA PACIFIC: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 113
TABLE 74 LATIN AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 113
TABLE 75 PURIFICATION KITS & REAGENTS MARKET, BY REGION,
2022–2029 (USD MILLION) 114
TABLE 76 NORTH AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 114
TABLE 77 EUROPE: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 78 ASIA PACIFIC: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 79 LATIN AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 80 CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY REGION,
2022–2029 (USD MILLION) 116
TABLE 81 NORTH AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 116
TABLE 82 EUROPE: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 83 ASIA PACIFIC: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 84 LATIN AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 85 OTHER PURIFICATION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 118
TABLE 86 NORTH AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 87 EUROPE: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 119
TABLE 88 ASIA PACIFIC: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 89 LATIN AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 90 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION) 120
TABLE 91 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION) 120
TABLE 92 NORTH AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 93 EUROPE: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 94 ASIA PACIFIC: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 95 LATIN AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 96 ANALYSIS KITS & REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 97 NORTH AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 123
TABLE 98 EUROPE: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 123
TABLE 99 ASIA PACIFIC: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 123
TABLE 100 LATIN AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 124
TABLE 101 OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 102 NORTH AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 103 EUROPE: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 104 ASIA PACIFIC: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 105 LATIN AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 106 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 107 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 108 EUROPE: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 109 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 127
TABLE 110 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 111 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 130
TABLE 112 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 113 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 114 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 115 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 116 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 117 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES,
BY REGION, 2022–2029 (USD MILLION) 133
TABLE 118 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 119 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 120 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 121 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 122 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 123 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 124 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 125 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 126 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 127 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER,
2022–2029 (USD MILLION) 138
TABLE 128 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 129 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 139
TABLE 130 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 131 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 140
TABLE 132 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 141
TABLE 133 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022–2029 (USD MILLION) 141
TABLE 134 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 135 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 136 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 137 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 138 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION) 143
TABLE 139 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 140 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 141 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 142 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 143 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 147
TABLE 144 MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 148
TABLE 145 NORTH AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 146 EUROPE: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 147 ASIA PACIFIC: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 148 LATIN AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 149 MRNA PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 150
TABLE 150 NORTH AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 150
TABLE 151 EUROPE: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 150
TABLE 152 ASIA PACIFIC: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 151
TABLE 153 LATIN AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 151
TABLE 154 MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 152
TABLE 155 NORTH AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 156 EUROPE: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 157 ASIA PACIFIC: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 158 LATIN AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 159 MANUFACTURING & SCALE-UP SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 154
TABLE 160 NORTH AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 161 EUROPE: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 155
TABLE 162 ASIA PACIFIC: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 163 LATIN AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 164 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER,
2022–2029 (USD MILLION) 157
TABLE 165 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 166 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 158
TABLE 167 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 159
TABLE 168 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 159
TABLE 169 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2022–2029 (USD MILLION) 160
TABLE 170 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 171 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 172 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 173 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 174 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 175 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY REGION, 2022–2029 (USD MILLION) 163
TABLE 176 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 177 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 163
TABLE 178 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 179 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 180 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY REGION,
2022–2029 (USD MILLION) 166
TABLE 181 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY REGION,
2022–2029 (USD MILLION) 166
TABLE 182 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 183 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 184 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 168
TABLE 185 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 169
TABLE 186 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 169
TABLE 187 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 169
TABLE 188 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 170
TABLE 189 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 170
TABLE 190 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022–2029 (USD MILLION) 170
TABLE 191 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 171
TABLE 192 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022–2029 (USD MILLION) 171
TABLE 193 MACROECONOMIC INDICATORS FOR NORTH AMERICA 172
TABLE 194 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 173
TABLE 195 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES,
2022–2029 (USD MILLION) 173
TABLE 196 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 173
TABLE 197 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 174
TABLE 198 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 174
TABLE 199 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 174
TABLE 200 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 175
TABLE 201 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 175
TABLE 202 US: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 175
TABLE 203 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 176
TABLE 204 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 176
TABLE 205 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 177
TABLE 206 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 177
TABLE 207 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 177
TABLE 208 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 178
TABLE 209 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 178
TABLE 210 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 178
TABLE 211 CANADA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 179
TABLE 212 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 213 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 214 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 180
TABLE 215 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 180
TABLE 216 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 181
TABLE 217 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 181
TABLE 218 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 181
TABLE 219 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 182
TABLE 220 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 182
TABLE 221 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 182
TABLE 222 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 183
TABLE 223 MACROECONOMIC INDICATORS FOR EUROPE 184
TABLE 224 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 184
TABLE 225 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 185
TABLE 226 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 185
TABLE 227 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 186
TABLE 228 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 186
TABLE 229 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 186
TABLE 230 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 187
TABLE 231 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 187
TABLE 232 GERMANY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 187
TABLE 233 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 188
TABLE 234 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES,
2022–2029 (USD MILLION) 188
TABLE 235 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 189
TABLE 236 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 189
TABLE 237 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 189
TABLE 238 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 190
TABLE 239 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 190
TABLE 240 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 190
TABLE 241 UK: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 191
TABLE 242 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 191
TABLE 243 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 192
TABLE 244 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 192
TABLE 245 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 193
TABLE 246 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 193
TABLE 247 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 193
TABLE 248 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022–2029 (USD MILLION) 194
TABLE 249 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 194
TABLE 250 FRANCE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 194
TABLE 251 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 195
TABLE 252 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 195
TABLE 253 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 196
TABLE 254 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 196
TABLE 255 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 196
TABLE 256 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 197
TABLE 257 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 197
TABLE 258 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 197
TABLE 259 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 198
TABLE 260 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 198
TABLE 261 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 199
TABLE 262 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 199
TABLE 263 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 200
TABLE 264 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 200
TABLE 265 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 200
TABLE 266 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 201
TABLE 267 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 201
TABLE 268 ITALY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 201
TABLE 269 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 202
TABLE 270 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 202
TABLE 271 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 203
TABLE 272 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 203
TABLE 273 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 203
TABLE 274 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 204
TABLE 275 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 204
TABLE 276 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 204
TABLE 277 SPAIN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 205
TABLE 278 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 205
TABLE 279 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 206
TABLE 280 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 206
TABLE 281 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 207
TABLE 282 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 207
TABLE 283 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 207
TABLE 284 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022–2029 (USD MILLION) 208
TABLE 285 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 208
TABLE 286 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022–2029 (USD MILLION) 208
TABLE 287 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 288 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 289 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 210
TABLE 290 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 211
TABLE 291 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 211
TABLE 292 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 212
TABLE 293 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 212
TABLE 294 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 212
TABLE 295 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 213
TABLE 296 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 213
TABLE 297 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY END USER, 2022–2029 (USD MILLION) 213
TABLE 298 MACROECONOMIC INDICATORS FOR ASIA PACIFIC 214
TABLE 299 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 215
TABLE 300 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 215
TABLE 301 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 215
TABLE 302 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 216
TABLE 303 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 216
TABLE 304 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 216
TABLE 305 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 217
TABLE 306 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 217
TABLE 307 CHINA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 217
TABLE 308 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 218
TABLE 309 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 218
TABLE 310 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 219
TABLE 311 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 219
TABLE 312 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 220
TABLE 313 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 220
TABLE 314 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 220
TABLE 315 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 221
TABLE 316 JAPAN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 221
TABLE 317 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 222
TABLE 318 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 222
TABLE 319 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 222
TABLE 320 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 223
TABLE 321 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 223
TABLE 322 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 223
TABLE 323 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 224
TABLE 324 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 224
TABLE 325 INDIA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 224
TABLE 326 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 225
TABLE 327 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 225
TABLE 328 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 226
TABLE 329 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 226
TABLE 330 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 227
TABLE 331 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 227
TABLE 332 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 227
TABLE 333 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 228
TABLE 334 SOUTH KOREA: MRNA SYNTHESIS AND MANUFACTURING SERVICE MARKET,
BY END USER, 2022–2029 (USD MILLION) 228
TABLE 335 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 229
TABLE 336 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 229
TABLE 337 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 230
TABLE 338 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 230
TABLE 339 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 230
TABLE 340 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 231
TABLE 341 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 231
TABLE 342 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY SERVICE, 2022–2029 (USD MILLION) 231
TABLE 343 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 232
TABLE 344 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 345 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET,
BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 346 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 233
TABLE 347 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 233
TABLE 348 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 234
TABLE 349 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 234
TABLE 350 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 234
TABLE 351 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 235
TABLE 352 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022–2029 (USD MILLION) 235
TABLE 353 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 235
TABLE 354 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 236
TABLE 355 MACROECONOMIC INDICATORS FOR LATIN AMERICA 236
TABLE 356 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 237
TABLE 357 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 237
TABLE 358 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 238
TABLE 359 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 238
TABLE 360 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 238
TABLE 361 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 239
TABLE 362 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 239
TABLE 363 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 239
TABLE 364 BRAZIL: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 240
TABLE 365 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PRODUCT, 2022–2029 (USD MILLION) 240
TABLE 366 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 241
TABLE 367 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 241
TABLE 368 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 241
TABLE 369 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 242
TABLE 370 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 242
TABLE 371 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 242
TABLE 372 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY SERVICE, 2022–2029 (USD MILLION) 243
TABLE 373 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 243
TABLE 374 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 244
TABLE 375 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY CONSUMABLES, 2022–2029 (USD MILLION) 244
TABLE 376 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET,
BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 245
TABLE 377 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 245
TABLE 378 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 245
TABLE 379 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 246
TABLE 380 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY END USER, 2022–2029 (USD MILLION) 246
TABLE 381 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022–2029 (USD MILLION) 246
TABLE 382 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 247
TABLE 383 MACROECONOMIC INDICATORS FOR MIDDLE EAST 247
TABLE 384 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2022–2029 (USD MILLION) 248
TABLE 385 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022–2029 (USD MILLION) 248
TABLE 386 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022–2029 (USD MILLION) 249
TABLE 387 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022–2029 (USD MILLION) 249
TABLE 388 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022–2029 (USD MILLION) 249
TABLE 389 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET,
BY APPLICATION, 2022–2029 (USD MILLION) 250
TABLE 390 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022–2029 (USD MILLION) 250
TABLE 391 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2022–2029 (USD MILLION) 250
TABLE 392 AFRICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022–2029 (USD MILLION) 251
TABLE 393 MACROECONOMIC INDICATORS FOR AFRICA 251
TABLE 394 OVERVIEW OF STRATEGIES ADOPTED BY KEY MRNA SYNTHESIS & MANUFACTURING COMPANIES, JANUARY 2021–AUGUST 2024 252
TABLE 395 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: DEGREE OF COMPETITION, 2023 255
TABLE 396 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: RANKING ANALYSIS OF TOP 5 PLAYERS, 2023 256
TABLE 397 MRNA SYNTHESIS & MANUFACTURING MARKET: REGION FOOTPRINT 263
TABLE 398 MRNA SYNTHESIS & MANUFACTURING MARKET: PRODUCT FOOTPRINT 264
TABLE 399 MRNA SYNTHESIS & MANUFACTURING MARKET: SERVICE FOOTPRINT 265
TABLE 400 MRNA SYNTHESIS & MANUFACTURING MARKET: APPLICATION FOOTPRINT 266
TABLE 401 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY STARTUPS/SMES 268
TABLE 402 MRNA SYNTHESIS AND MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 269
TABLE 403 MRNA SYNTHESIS & MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2024 270
TABLE 404 MRNA SYNTHESIS & MANUFACTURING MARKET: DEALS,
JANUARY 2021–AUGUST 2024 271
TABLE 405 MRNA SYNTHESIS & MANUFACTURING MARKET: EXPANSIONS,
JANUARY 2021–AUGUST 2024 271
TABLE 406 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 273
TABLE 407 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 274
TABLE 408 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 276
TABLE 409 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024 276
TABLE 410 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–AUGUST 2024 276
TABLE 411 DANAHER CORPORATION: COMPANY OVERVIEW 278
TABLE 412 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 279
TABLE 413 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 281
TABLE 414 DANAHER CORPORATION: DEALS, JANUARY 2021–AUGUST 2024 281
TABLE 415 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024 281
TABLE 416 MERCK KGAA: COMPANY OVERVIEW 283
TABLE 417 MERCK KGAA: PRODUCTS/SERVICES OFFERED 284
TABLE 418 MERCK KGAA: DEALS, JANUARY 2021–AUGUST 2024 287
TABLE 419 MERCK KGAA: EXPANSIONS, JANUARY 2021–AUGUST 2024 287
TABLE 420 LONZA: COMPANY OVERVIEW 289
TABLE 421 LONZA: PRODUCTS/SERVICES OFFERED 290
TABLE 422 LONZA: DEALS, JANUARY 2021–AUGUST 2024 291
TABLE 423 LONZA: EXPANSIONS, JANUARY 2021–AUGUST 2024 291
TABLE 424 MARVAI LIFESCIENCES: COMPANY OVERVIEW 293
TABLE 425 MARVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED 294
TABLE 426 MARVAI LIFESCIENCES: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 297
TABLE 427 MARVAI LIFESCIENCE: DEALS, JANUARY 2021–AUGUST 2024 297
TABLE 428 MARVAI LIFESCIENCES: EXPANSIONS, JANUARY 2021–AUGUST 2024 298
TABLE 429 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 299
TABLE 430 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED 299
TABLE 431 NEW ENGLAND BIOLABS: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–AUGUST 2024 300
TABLE 432 PROMEGA CORPORATION: COMPANY OVERVIEW 301
TABLE 433 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 301
TABLE 434 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2024 302
TABLE 435 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024 302
TABLE 436 GENSCRIPT: COMPANY OVERVIEW 303
TABLE 437 GENSCRIPT: PRODUCTS/SERVICES OFFERED 304
TABLE 438 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2024 305
TABLE 439 GENSCRIPT: DEALS, JANUARY 2021– AUGUST 2024 306
TABLE 440 GENSCRIPT: EXPANSIONS, JANUARY 2021–AUGUST 2024 306
TABLE 441 WUXI BIOLOGICS: COMPANY OVERVIEW 308
TABLE 442 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED 309
TABLE 443 WUXI BIOLOGICS: EXPANSIONS, JANUARY 2021–AUGUST 2024 310
TABLE 444 TAKARA BIO INC.: COMPANY OVERVIEW 311
TABLE 445 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 312
TABLE 446 TAKARA BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2024 313
TABLE 447 TAKARA BIO INC.: DEALS, JANUARY 2021–AUGUST 2024 313
TABLE 448 SARTORIUS AG: COMPANY OVERVIEW 314
TABLE 449 SARTORIUS AG: PRODUCTS/SERVICES OFFERED 315
TABLE 450 SARTORIUS AG: DEALS, JANUARY 2021–AUGUST 2024 316
TABLE 451 GENEWIZ: COMPANY OVERVIEW 317
TABLE 452 GENEWIZ: PRODUCTS/SERVICES OFFERED 318
TABLE 453 TELESIS BIO INC.: COMPANY OVERVIEW 319
TABLE 454 TELESIS BIO INC.: PRODUCTS/SERVICES OFFERED 320
TABLE 455 TELESIS BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2024 321
TABLE 456 TELESIS BIO INC.: DEALS, JANUARY 2021–AUGUST 2024 321
TABLE 457 ST PHARM: COMPANY OVERVIEW 322
TABLE 458 ST PHARM: PRODUCTS/SERVICES OFFERED 323
TABLE 459 ST PHARM: DEALS, JANUARY 2021–AUGUST 2024 323
TABLE 460 AGC BIOLOGICS: COMPANY OVERVIEW 324
TABLE 461 AGC BIOLOGICS: PRODUCTS/SERVICES OFFERED 324
TABLE 462 AGC BIOLOGICS: DEALS, JANUARY 2021–AUGUST 2024 325
TABLE 463 AGC BIOLOGICS: EXPANSIONS, JANUARY 2021–AUGUST 2024 325
TABLE 464 DR. REDDY’S LABORATORIES LTD.: COMPANY OVERVIEW 326
TABLE 465 DR. REDDY’S LABORATORIES LTD.: PRODUCTS/SERVICES OFFERED 327
TABLE 466 DR. REDDY’S LABORATORIES LTD.: EXPANSIONS, JANUARY 2021–AUGUST 2024 327
TABLE 467 ETHERNA: COMPANY OVERVIEW 328
TABLE 468 BOC SCIENCES: COMPANY OVERVIEW 329
TABLE 469 BIOMAY AG: COMPANY OVERVIEW 330
TABLE 470 CURIA GLOBAL, INC.: COMPANY OVERVIEW 331
TABLE 471 JENA BIOSCIENCE GMBH: COMPANY OVERVIEW 332
TABLE 472 ENZYNOMICS CO., LTD.: COMPANY OVERVIEW 333
TABLE 473 KANEKA EUROGENTEC S.A.: COMPANY OVERVIEW 334
TABLE 474 VERNAL BIOSCIENCES: COMPANY OVERVIEW 334
TABLE 475 CELLSCRIPT: COMPANY OVERVIEW 335
LIST OF FIGURES
FIGURE 1 MRNA SYNTHESIS & MANUFACTURING MARKET SEGMENTATION AND REGIONAL SCOPE 35
FIGURE 2 MRNA SYNTHESIS & MANUFACTURING MARKET: RESEARCH DESIGN 38
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY RESPONDENT, DESIGNATION, AND REGION 40
FIGURE 4 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 41
FIGURE 5 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 41
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR PRODUCT MARKET), 2023 42
FIGURE 7 MARKET SIZE ESTIMATION: APPROACH 2 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR SERVICE MARKET), 2023 43
FIGURE 8 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2023 43
FIGURE 9 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 45
FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 45
FIGURE 11 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: CAGR PROJECTIONS, 2024–2029 47
FIGURE 12 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: CAGR PROJECTIONS, 2024–2029 47
FIGURE 13 MRNA SYNTHESIS & MANUFACTURING MARKET: DATA TRIANGULATION METHODOLOGY 49
FIGURE 14 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT,
2024 VS. 2029 (USD MILLION) 51
FIGURE 15 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE,
2024 VS. 2029 (USD MILLION) 52
FIGURE 16 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 52
FIGURE 17 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER,
2024 VS. 2029 (USD MILLION) 53
FIGURE 18 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 54
FIGURE 19 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: GEOGRAPHICAL SNAPSHOT 55
FIGURE 20 EXPANDING APPLICATIONS OF MRNA TECHNOLOGY TO DRIVE MARKET 56
FIGURE 21 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 57
FIGURE 22 MRNA SYNTHESIS & MODIFICATION TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 57
FIGURE 23 MRNA SYNTHESIS & MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
FIGURE 24 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN MRNA SYNTHESIS & MANUFACTURING MARKET 66
FIGURE 25 MRNA SYNTHESIS & MANUFACTURING MARKET: VALUE CHAIN ANALYSIS 71
FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT,
2021–2023 (USD) 76
FIGURE 27 AVERAGE SELLING PRICE TREND, BY CONSUMABLES, 2021–2023 (USD) 77
FIGURE 28 AVERAGE SELLING PRICE, BY REGION, 2023 (USD) 77
FIGURE 29 MRNA SYNTHESIS & MANUFACTURING MARKET: PATENT ANALYSIS, 2014–2024 78
FIGURE 30 MRNA SYNTHESIS & MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS 81
FIGURE 31 MRNA SYNTHESIS & MANUFACTURING MARKET: ECOSYSTEM ANALYSIS 82
FIGURE 32 MRNA SYNTHESIS & MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS 84
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 86
FIGURE 34 KEY BUYING CRITERIA, BY END USER (PRODUCT) 87
FIGURE 35 RESEARCH FUNDING FOR MRNA SYNTHESIS & MANUFACTURING BY INSTITUTES AND CENTERS, 2021–2024 (USD MILLION) 88
FIGURE 36 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET 89
FIGURE 37 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY VOLUME, 2022–2029 91
FIGURE 38 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT 167
FIGURE 39 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT 209
FIGURE 40 MRNA SYNTHESIS & MANUFACTURING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD MILLION) 254
FIGURE 41 MRNA SYNTHESIS & MANUFACTURING MARKET SHARE ANALYSIS, 2023 255
FIGURE 42 EV/EBITDA OF KEY VENDORS 257
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 258
FIGURE 44 MRNA SYNTHESIS & MANUFACTURING MARKET: BRAND/SERVICE COMPARISON 259
FIGURE 45 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 262
FIGURE 46 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY FOOTPRINT 263
FIGURE 47 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 268
FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 274
FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 279
FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT (2023) 284
FIGURE 51 LONZA: COMPANY SNAPSHOT (2023) 290
FIGURE 52 MARVAI LIFESCIENCES: COMPANY SNAPSHOT (2023) 294
FIGURE 53 GENSCRIPT: COMPANY SNAPSHOT (2023) 304
FIGURE 54 WUXI BIOLOGICS: COMPANY SNAPSHOT (2023) 308
FIGURE 55 TAKARA BIO INC.: COMPANY SNAPSHOT (2023) 312
FIGURE 56 SARTORIUS AG: COMPANY SNAPSHOT (2023) 315
FIGURE 57 GENEWIZ: COMPANY SNAPSHOT (2023) 318
FIGURE 58 TELESIS BIO INC.: COMPANY SNAPSHOT (2023) 320
FIGURE 59 ST PHARM: COMPANY SNAPSHOT (2023) 322
FIGURE 60 DR. REDDY’S LABORATORIES LTD.: COMPANY SNAPSHOT (2023) 326
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11